Business Description
Harrow Inc
NAICS : 325412
SIC : 2834
ISIN : US45323A2015
Description
Harrow Inc is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market. Harrow helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans each year.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.39 | |||||
| Equity-to-Asset | 0.27 | |||||
| Debt-to-Equity | 2.5 | |||||
| Debt-to-EBITDA | 7.91 | |||||
| Interest Coverage | 0.2 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.16 | |||||
| Beneish M-Score | -0.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.6 | |||||
| 3-Year EBITDA Growth Rate | 41.3 | |||||
| 3-Year FCF Growth Rate | -86.6 | |||||
| 3-Year Book Growth Rate | -5.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.73 | |||||
| 9-Day RSI | 36.28 | |||||
| 14-Day RSI | 34.19 | |||||
| 6-1 Month Momentum % | -31.06 | |||||
| 12-1 Month Momentum % | 11.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.8 | |||||
| Quick Ratio | 5.33 | |||||
| Cash Ratio | 3.88 | |||||
| Days Inventory | 81.24 | |||||
| Days Sales Outstanding | 39.53 | |||||
| Days Payable | 106.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.4 | |||||
| Shareholder Yield % | -16.75 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.78 | |||||
| Operating Margin % | 3.09 | |||||
| Net Margin % | -12.45 | |||||
| FCF Margin % | -146.24 | |||||
| ROE % | -47.72 | |||||
| ROA % | -7.22 | |||||
| ROIC % | 3.14 | |||||
| ROC (Joel Greenblatt) % | 78.68 | |||||
| ROCE % | 7.76 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.53 | |||||
| PB Ratio | 4.32 | |||||
| EV-to-EBIT | 32.18 | |||||
| EV-to-EBITDA | 18.48 | |||||
| EV-to-Revenue | 3.88 | |||||
| EV-to-FCF | -2.65 | |||||
| Earnings Yield (Greenblatt) % | 3.11 | |||||
| FCF Yield % | -51.01 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HROW
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Harrow Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 114.167 | ||
| EPS (TTM) ($) | -0.45 | ||
| Beta | -0.33 | ||
| Volatility % | 75.9 | ||
| 14-Day RSI | 34.19 | ||
| 14-Day ATR ($) | 0.717635 | ||
| 20-Day SMA ($) | 10.45425 | ||
| 12-1 Month Momentum % | 11.62 | ||
| 52-Week Range ($) | 7.6 - 28.25 | ||
| Shares Outstanding (Mil) | 35.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Harrow Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Harrow Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Harrow Inc Frequently Asked Questions
What is Harrow Inc(HROW)'s stock price today?
The current price of HROW is $9.32. The 52 week high of HROW is $28.25 and 52 week low is $7.60.
When is next earnings date of Harrow Inc(HROW)?
The next earnings date of Harrow Inc(HROW) is 2024-03-22 Est..
Does Harrow Inc(HROW) pay dividends? If so, how much?
Harrow Inc(HROW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers